The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
We’ve Got Your BAK
Imagine a world where you could use as much preservative as you needed in a prescription eye drop without ever having to worry it would ...
OIS Index Outperforms
The OIS Index of ophthalmic stocks gained 5.4% in November, following a similar 5.2% gain in October. The index outperformed medical device stocks (+4.3%) and ...
CorneaGen Aims to End Corneal Blindness
CorneaGen’s approach to treating corneal blindness is to prevent it from ever occurring, said Monty Montoya, president and CEO, who added no other organization has ...
RegenxBio sues FDA over clinical hold
Days after the U.S. Food and Drug Administration placed a partial hold on RGX-314, RegenxBio (NASDAQ: RGNX) lead gene therapy agent, the company initially outlined ...
Bausch, Clearside See Gains Post-Deal
When it comes to the stock market, Bausch Health’s has been rising steadily, up 4.1% in the past month, and on November 13 hit a ...
Oyster Point Pharma Goes Public
Oyster Point Pharma is now officially listed on the Nasdaq Global Market under “OYST.” Initial share pricing was $16; to date the stock’s high has ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.